Skip to content

Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations

Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03100461
Acronym
AIMSS
Enrollment
500
Registered
2017-04-04
Start date
2018-01-22
Completion date
2022-09-30
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Cancer Screening, Colon Cancer, Colon Cancer Screening

Brief summary

The goal of this study is to find the best ways to increase colorectal cancer (CRC) screening.

Detailed description

Colorectal Cancer is preventable and curable but is still the second most common cause of cancer death in the U.S. Minorities and those with low income have more CRC than middle and high income Whites.. They also get fewer CRC screening tests. Low knowledge of CRC screening may, in part, drive this lower test use. We need new ways to improve CRC screening in primary care clinics where many minority and uninsured patients receive health care.

Interventions

OTHERI2

A touch screen computer delivered implementation intentions (I2) intervention on CRC screening. Implementation intentions are the exact steps (the when, what, where, how) one will take to complete a test (the date and time, at home or at the doctor's office, with what supplies, etc.).

OTHERHealth Education

Standard of care approach that will provide basic information on CRC screening.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Have a home address and access to a working telephone * Pass Mini-Cog assessment

Exclusion criteria

* FIT (fecal immunochemical test) test within 1 year, Sigmoidoscopy or Barium enema within 5 years, or Colonoscopy within 10 years * Acute medical illness, * current GI bleed * history of adenomatous polyps * Colorectal Cancer * 1st degree relative with CRC \< age 60 years * inherited polyposis/non-polyposis syndrome * inflammatory bowel disease * Another household member enrolled in the study

Design outcomes

Primary

MeasureTime frameDescription
CRC screening completion rate12-14 MonthsRate of participants who receive CRC screening during study participation

Secondary

MeasureTime frameDescription
Cost analysis of each intervention pathway14 MonthsMeasure will be calculated by estimating all cost factors in the CRC screening process, include personnel and materials/supplies costs, materials development costs, and time of all study staff involved. Measure represented as a per participant cost to complete screening.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026